PCSK1 and chronic myelogenous leukemia, BCR-ABL1 positive: In cultured CML cells as well as in 32Dp210-T315I tumors in vivo, shikonin-induced CML cell death could be largely rescued by Nec-1, a selective RIP1 kinase inhibitor that blocks necroptosis, but not by apoptosis in different cells [33].